Literature DB >> 31871111

FOXA1 Protein Expression in ER+ and ER- Breast Cancer in Relation to Parity and Breastfeeding in Black and White Women.

Ting-Yuan David Cheng1,2, Song Yao2, Angela R Omilian2, Thaer Khoury3, Matthew F Buas2, Rochelle Payne-Ondracek2, Sirinapa Sribenja4, Wiam Bshara3, Chi-Chen Hong2, Elisa V Bandera5, Warren Davis2, Michael J Higgins4, Christine B Ambrosone2.   

Abstract

BACKGROUND: Forkhead box protein A1 (FOXA1) promotes luminal differentiation, and hypermethylation of the gene can be a mechanism of developing estrogen receptor-negative (ER-) breast cancer. We examined FOXA1 in breast tumor and adjacent normal tissue in relation to reproductive factors, particularly higher parity and no breastfeeding, that are associated with ER- tumors.
METHODS: We performed IHC for FOXA1 in breast tumors (n = 1,329) and adjacent normal tissues (n = 298) in the Women's Circle of Health Study (949 Blacks and 380 Whites). Protein expression levels were summarized by histology (H) scores. Generalized linear models were used to assess FOXA1 protein expression in relation to reproductive factors by ER status.
RESULTS: ER-positive (ER+) versus ER- tumors had higher FOXA1 protein expression (P < 0.001). FOXA1 expression was higher in tumor versus paired adjacent normal tissue in women with ER+ or non-triple-negative cancer (both P < 0.001), but not in those with ER- or triple-negative cancer. Higher number of births (1, 2, and 3+) was associated with lower FOXA1 protein expression in ER+ tumors [differences in H score, or β = -8.5; 95% confidence interval (CI), -15.1 to -2.0], particularly among parous women who never breastfed (β = -10.4; 95% CI, -19.7 to -1.0), but not among those who breastfed (β = -7.5; 95% CI, -16.9 to 1.8). The associations for ER- tumors were similar, although they were not statistically significant.
CONCLUSIONS: In this tumor-based study, higher parity was associated with lower FOXA1 expression in ER+ tumors, and breastfeeding may ameliorate the influence. IMPACT: These findings contribute to our understanding of FOXA1 methylation and breast cancer etiology. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31871111      PMCID: PMC7007352          DOI: 10.1158/1055-9965.EPI-19-0787

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  38 in total

1.  Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer.

Authors:  Anton Safonov; Tingting Jiang; Giampaolo Bianchini; Balázs Győrffy; Thomas Karn; Christos Hatzis; Lajos Pusztai
Journal:  Cancer Res       Date:  2017-04-20       Impact factor: 12.701

2.  FOXA1 and breast cancer risk.

Authors:  Kerstin B Meyer; Jason S Carroll
Journal:  Nat Genet       Date:  2012-11       Impact factor: 38.330

3.  FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?

Authors:  Allyson C Espinal; Matthew F Buas; Dan Wang; David Ting-Yuan Cheng; Lara Sucheston-Campbell; Qiang Hu; Li Yan; Rochelle Payne-Ondracek; Eduardo Cortes; Li Tang; Zhihong Gong; Gary Zirpoli; Thaer Khoury; Song Yao; Angela Omilian; Kitaw Demissie; Elisa V Bandera; Song Liu; Christine B Ambrosone; Michael J Higgins
Journal:  Breast Cancer Res Treat       Date:  2017-07-29       Impact factor: 4.872

4.  Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1.

Authors:  Sagar Ghosh; Fei Gu; Chou-Miin Wang; Chun-Lin Lin; Joseph Liu; Howard Wang; Peter Ravdin; Yanfen Hu; Tim H M Huang; Rong Li
Journal:  Breast Cancer Res Treat       Date:  2014-09-19       Impact factor: 4.872

5.  Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.

Authors:  Erica T Warner; Rulla M Tamimi; Melissa E Hughes; Rebecca A Ottesen; Yu-Ning Wong; Stephen B Edge; Richard L Theriault; Douglas W Blayney; Joyce C Niland; Eric P Winer; Jane C Weeks; Ann H Partridge
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

Review 6.  Pregnancy-associated breast cancer and metastasis.

Authors:  Pepper Schedin
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

7.  Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study.

Authors:  Christine B Ambrosone; Gary Zirpoli; Melanie Ruszczyk; Jyoti Shankar; Chi-Chen Hong; Demetra McIlwain; Michelle Roberts; Song Yao; Susan E McCann; Gregory Ciupak; Helena Hwang; Thaer Khoury; Lina Jandorf; Dana H Bovbjerg; Karen Pawlish; Elisa V Bandera
Journal:  Cancer Causes Control       Date:  2013-11-19       Impact factor: 2.506

Review 8.  Milk's Role as an Epigenetic Regulator in Health and Disease.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Diseases       Date:  2017-03-15

9.  Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Authors:  M A Thorat; C Marchio; A Morimiya; K Savage; H Nakshatri; J S Reis-Filho; S Badve
Journal:  J Clin Pathol       Date:  2007-11-23       Impact factor: 3.411

10.  Rethinking sources of representative controls for the conduct of case-control studies in minority populations.

Authors:  Elisa V Bandera; Urmila Chandran; Gary Zirpoli; Susan E McCann; Gregory Ciupak; Christine B Ambrosone
Journal:  BMC Med Res Methodol       Date:  2013-05-31       Impact factor: 4.615

View more
  5 in total

1.  Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.

Authors:  Song Yao; Peter T Campbell; Tomotaka Ugai; Gretchen Gierach; Montserrat Garcia-Closas; Timothy R Rebbeck; Christine B Ambrosone; Shuji Ogino; Mustapha Abubakar; Viktor Adalsteinsson; Jonas Almeida; Paul Brennan; Stephen Chanock; Todd Golub; Samir Hanash; Curtis Harris; Cassandra A Hathaway; Karl Kelsey; Maria Teresa Landi; Faisal Mahmood; Christina Newton; John Quackenbush; Scott Rodig; Nikolaus Schultz; Guillermo Tearney; Shelley S Tworoger; Molin Wang; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2022-06-27       Impact factor: 2.532

Review 2.  Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice.

Authors:  Christine B Ambrosone; Michael J Higgins
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

3.  Deletion of Foxa1 in the mouse mammary gland results in abnormal accumulation of luminal progenitor cells: a link between reproductive factors and ER-/TNBC breast cancer?

Authors:  Sirinapa Sribenja; Orla Maguire; Kristopher Attwood; Matthew F Buas; Julie R Palmer; Christine B Ambrosone; Michael J Higgins
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 4.  Genome-Wide Estrogen Receptor Activity in Breast Cancer.

Authors:  Anca M Farcas; Sankari Nagarajan; Sabina Cosulich; Jason S Carroll
Journal:  Endocrinology       Date:  2021-02-01       Impact factor: 4.736

5.  FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact.

Authors:  Jasna Metovic; Fulvio Borella; Marta D'Alonzo; Nicoletta Biglia; Luca Mangherini; Cristian Tampieri; Luca Bertero; Paola Cassoni; Isabella Castellano
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.